PT-141 (Bremelanotide) 10 mg – Melanocortin-Receptor Research Peptide
FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION.
Scientific Background
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide
under investigation for selective agonist activity at melanocortin
receptors MC3R and MC4R. Current in-vitro studies examine receptor-binding
kinetics, intracellular cAMP signaling, and downstream neuroendocrine pathways.
Specification
- Peptide Name: PT-141 (Bremelanotide)
- Content: 10 mg lyophilized powder (requires reconstitution)
- Purity: ≥ 99 % (HPLC / MS certificate available)
- Manufacturing: ISO 9001:2015 & cGMP-audited facility
- Intended Use: In-vitro laboratory research only
Storage & Handling
- Prior to reconstitution: store ≤ 8 °C in a dry environment
- After reconstitution: refrigerate 2 – 8 °C and use within 30 days
- For long-term preservation: aliquot and freeze at −20 °C
- Avoid repeated freeze–thaw cycles
Compliance Notice
Supplied exclusively to qualified professionals for controlled laboratory
applications. No dosage or administration guidance is provided. Buyer assumes
responsibility for safe handling and regulatory adherence.
Lab Results / COA
Previous Certificates of Analysis
- PT1010232025-05 – Date: 24 OCT ’25
- PT1008272025-04 – Date: 01 SEP ’25
- PT1007132025-03 – Date: 16 JUL ’25
Additional Information
| Weight | .2 lbs |
|---|---|
| Dimensions | 2 × 2 × 2 in |
